For this reason, it would be prudent to monitor for drowsiness during concurrent use of loratadine with CNS depressants such as other H1-blockers.Īcetaminophen Chlorpheniramine Dextromethorphan: (Minor) Although loratadine is considered a 'non-sedating' antihistamine, dose-related sedation has been noted. For this reason, it would be prudent to monitor for drowsiness during concurrent use of loratadine with CNS depressants such as other H1-blockers.Īcetaminophen Chlorpheniramine: (Minor) Although loratadine is considered a 'non-sedating' antihistamine, dose-related sedation has been noted. For this reason, it would be prudent to monitor for drowsiness during concurrent use of loratadine with CNS depressants such as other H1-blockers.Īcetaminophen Caffeine Pyrilamine: (Minor) Although loratadine is considered a 'non-sedating' antihistamine, dose-related sedation has been noted. Ocular pain / Early / Incidence not knownĪcetaminophen Aspirin Diphenhydramine: (Minor) Although loratadine is considered a 'non-sedating' antihistamine, dose-related sedation has been noted. Urine discoloration / Early / Incidence not known Photosensitivity / Delayed / Incidence not known Mastalgia / Delayed / Incidence not known Menorrhagia / Delayed / Incidence not knownīreast enlargement / Delayed / Incidence not knownĭysmenorrhea / Delayed / Incidence not known Libido decrease / Delayed / Incidence not known Irritability / Delayed / Incidence not known Laryngitis / Delayed / Incidence not known Nasal dryness / Early / Incidence not known Sinusitis / Delayed / Incidence not known Weight gain / Delayed / Incidence not known Paresthesias / Delayed / Incidence not knownĪppetite stimulation / Delayed / Incidence not known Muscle cramps / Delayed / Incidence not known Hypoesthesia / Delayed / Incidence not known Hyperhidrosis / Delayed / Incidence not knownĪrthralgia / Delayed / Incidence not known Hepatitis / Delayed / Incidence not knownīlurred vision / Early / Incidence not knownīlepharospasm / Early / Incidence not known Urinary incontinence / Early / Incidence not knownĮlevated hepatic enzymes / Delayed / Incidence not known Urinary retention / Early / Incidence not known Impotence (erectile dysfunction) / Delayed / Incidence not known Vaginitis / Delayed / Incidence not known Hemoptysis / Delayed / Incidence not knownĭepression / Delayed / Incidence not known Supraventricular tachycardia (SVT) / Early / Incidence not known Palpitations / Early / Incidence not known Peripheral edema / Delayed / Incidence not known Hypertension / Early / Incidence not knownĬhest pain (unspecified) / Early / Incidence not known Sinus tachycardia / Rapid / Incidence not known Hypotension / Rapid / Incidence not known Gastritis / Delayed / Incidence not known
Hypertonia / Delayed / Incidence not knownĬonstipation / Delayed / Incidence not known If a breast-feeding infant experiences an adverse effect related to a maternally ingested drug, healthcare providers are encouraged to report the adverse effect to the FDA. Consider the benefits of breast-feeding, the risk of potential infant drug exposure, and the risk of an untreated or inadequately treated condition. The British Society for Allergy and Clinical Immunology also recommends loratadine at the lowest dose as a preferred antihistamine in breast-feeding women. Because of its lack of sedation and low milk concentrations, maternal use would not be expected to cause adverse effects in breast-fed babies and loratadine is considered usually compatible with breast-feeding. Approximately 3 mcg would be expected to be excreted in the milk with a 10 mg dose. The calculated average and maximum expected exposures of loratadine and desloratadine in milk were 0.46% and 1.1% of the maternal weight-adjusted dose, respectively, after the 40 mg dose. The total amount excreted in milk over 48 hours was 11.7 mcg of loratadine and desloratadine. Average loratadine peak milk concentrations, 2 hours after administration, were 29.2 mcg/L (range 20.4 to 39 mcg/L) average desloratadine peak milk concentrations, 5.3 hours after loratadine administration, were 16 mcg/L (range 9 to 29.6 mcg/L). In one study, a single loratadine dose of 40 mg (4 times the usual dose) was administered to 6 lactating women.
DO I NEED TO TAKE CLARITIN EVERYDAY PROFESSIONAL
Loratadine and its metabolite, desloratadine, are excreted into breast milk breast-feeding women are advised to consult a healthcare professional prior to using loratadine. Quality Choice Allergy Relief Non-Drowsy: QlearQuil All Day & All Night Allergy Relief: Product should always be stored in the blister and only removed immediately before use
0 kommentar(er)
